Fundamental Research
Understanding basic biology and the cause of human disease
Translational Research
Advancing research to clinical breakthroughs for patients through drug discovery and collaborations
Education & Training
Cultivating the next generation of scientists through our graduate school, postdoctoral training programs and fellowships
The Latest News
-
Drug Discovery
Sanford Burnham Prebys awarded $4.5 million NIH grant for mental illness therapeutics
The funding supports the discovery of new classes of drugs that target “orphan” receptors to treat psychological conditions such as schizophrenia, depression, anxiety and substance abuse. -
The findings are a first step toward a potential treatment for one of the deadliest cancers known today. -
Researchers are hoping the study shows how coronavirus affects people from different backgrounds. -
Multiple drugs improve the activity of remdesivir, a current standard-of-care treatment for COVID-19 -
The research team will test two existing drugs against “mini lungs in a dish” that have been infected with SARS-CoV-2. -
No treatments currently exist for the common condition that causes progressive vision loss. -
C. Randal “Randy” Mills now heads one of San Diego’s leading research institutes -
Mills joins the Institute with decades of experience as an entrepreneur and transformational leader in the biomedical industry. -
Funding for the research comes from the record setting $3.1 million raised in the 2019 event and brings the lifetime raise for PPTC to over $13 million. -
Study outlines how we might help more people respond to immunotherapy, an often life-saving treatment -
The grant is often a career-launching award for “rising stars” in cancer research -
Drug Discovery
Sanford Burnham Prebys announces research agreement with Lilly for COVID-19 antibody research
Neutralizing antibodies have the potential for both prevention and treatment of COVID-19.
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."
Next Generation
AACR selects Sanford Burnham Prebys scientist as NextGen Star
The American Association for Cancer Research (AACR) has named Cosimo Commisso, Ph.D., assistant professor in our NCI-designated Cancer Center, as a NextGen Star.
Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"
Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."
COVID-19 matching gift campaign
The power of investing in human health
Dinah Ruch is accelerating our COVID-19 efforts with a generous matching gift that doubles all donations dollar for dollar up to $500,000.
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.
Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.
Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.
Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
